Trial intelligence / Profile preview

Zolpidem for Sleep in Cannabis Use Disorder

NCT01685073Phase 3Completed

Sponsor
Johns Hopkins University
Start
Sep 2012
Primary completion
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of zolpidem in cannabis use disorder (CUD), sponsored by Johns Hopkins University. Started Sep 2012; status: completed.

02

Drugs

zolpidem
03

Conditions

cannabis use disorder (CUD)

Beyond the preview

Go deeper on NCT01685073.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01685073.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call